In vitro uptake of HDL-SAA by tissue macrophages during the development of AA amyloidosis in mice

References

• Glenner G G. Amyloid deposits and amyloidosis. The ß fibrilloses part I. New Eng J Med 1980; 302: 1283–1292
   PubMed Web of Science ®Google Scholar
• Shirahama T, Cohen A S. Intralysosomal formation of amyloid fibrils. Am J Pathol 1975; 81: 101–116
   PubMed Web of Science ®Google Scholar
• Chronopoulos S, Lembo P, Alizadeh-Khiavi K, Ali-Khan Z. Ubiquitin: its potential significance in murine AA amyloidogenesis. J Pathol 1992; 167: 249–259
   PubMed Web of Science ®Google Scholar
• Shirahama T, Miura K, Ju S T, Kisilevsky R, Grays E, Cohen A S. Amyloid enhancing factor-loaded macrophages in amyloid fibril formation. Lab Invest 1990; 62: 61–68
   PubMed Web of Science ®Google Scholar
• Rozemuller J M, Bots G TAM, Roos R AC, Elkelenboom P. Acute phase proteins but not activated microglial cells are present in parenchymal (3A4 deposits in the brains of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type. Neurosc Lett 1992; 140: 137–140
   Google Scholar
• Fuks A, Zucker-Franklin D. Impaired Kupffer cell function precedes development of secondary amyloidosis. J Exp Med 1985; 161: 1013–1028
   PubMed Web of Science ®Google Scholar
• Lavie G, Franklin E C, Zucker-Franklin D. Characterization of a series of elastase-like serine proteases on human peripheral blood monocytes that degrade SAA. Excerpta Medica 1980; 497: 448–455
   Google Scholar
• Lavie G, Zucker-Franklin D, Franklin E C. Elastase type proteases on the surface of human blood monocytes: possible role in amyloid formation. J Immunol 1980; 125: 1750–180
   Google Scholar
• Benditt E P, Eriksen N, Hanson R H. Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein. Proc Natl Acad Sci USA 1979; 76: 4092–4096
   PubMed Web of Science ®Google Scholar
• Binette P, Binette M, Calkins E. The isolation and identification of the P-component of normal human plasma proteins. Biochem J 1974; 143: 253–254
   Google Scholar
• Cathcart E S, Shirahama T, Cohen A S. Isolation and identification of a plasma component of amyloid. Biochem Biophys Acta 1967; 147: 392–393
   Web of Science ®Google Scholar
• Coria F, Castano E, Prelli F, Larrondo-Lillo M, van Duinen S, Shelanski M L, Frangione B. Isolation and characterization of amyloid P component in Alzheimer's disease and other types of cerebral amyloidosis. Lab Invest 1988; 58: 454–458
   PubMedGoogle Scholar
• Duong T, Pommier E C, Sheibel A B. Immunodetection of the amyloid P component in Alzheimer's disease. Acta Neuropathol 1989; 78: 429–437
   PubMed Web of Science ®Google Scholar
• Rowe I F, Jensson O, Lewis P D, Candy J, Tennent G A, Pepys M B. Immunohistochemical demonstration of amyloid P component in cerebrovascular amyloidosis. Neuropathol Appl Neurobiol 1984; 10: 53–61
   PubMedGoogle Scholar
• Skinner M, Cohen A S, Shirahama T, Cathcart E S. P-component (pentagonal unit) of amyloid: isolation, characterization and sequence analysis. J Lab Clin Med 1974; 84: 604–614
   PubMedGoogle Scholar
• Westermark P, Skinner M, Cohen A S. The P-component of amyloid of human islets of Langerhans. Scand J Immunol 1975; 4: 95–97
   PubMedGoogle Scholar
• Baltz M L, Gomer K, Davies A JS, Evans D J, Klaus F FB, Pepys M D. Differences in the acute phase responses of serum amyloid P-component (SAP) and C3 to injections of casein or bovine serum albumin in amyloid-susceptible and -resistant mouse strains. Clin Exp Immunol 1980; 39: 355–360
   Google Scholar
• Tashiro F, Yi S, Wakasugi S, Maeda S. Role of serum amyloid P component for systemic amyloidosis in transgenic mice carrying human mutant transthyretin gene. Gerontology 1991; 37(Suppl. 1)56–62
   PubMed Web of Science ®Google Scholar
• Li J J, McAdam K PW. J. Human amyloid P component: an elastase inhibitor. Scand J Immunol 1984; 20: 219–226
   PubMed Web of Science ®Google Scholar
• Vachino G, Heck L W, Gelfand J A, Kaplan M M, Burke J F, Berninger R W, McAdam K PWJ. Inhibition of human neutrophil and Pseudomonas elastases by the amyloid P-component: a constituent of elastic fibers and amyloid deposits. J Leuk Biol 1988; 44: 529–534
   PubMedGoogle Scholar
• Sarlo K T, Mortensen R F. Enhanced Interleukin-1 (IL-1) production mediated by mouse serum amyloid P-component. Cell Immunol 1985; 93: 398–405
   Google Scholar
• Singh P P, Gervais F, Skamene E, Mortensen R F. Serum amyloid P component-induced enhancement of macrophage Listericidal activity. Infect Immun 1986; 52: 688–694
   Google Scholar
• Reid C, Hébert L, Pozzulo G, Gervais F. Splenic macrophage activation and functions in amyloid-enhancing factor-induced secondary amyloidosis. Study of phagocytosis, killing, respiratory burst and MHC Class II surface expression. J Leuk Biol 1993; 53: 651–657
   PubMedGoogle Scholar
• Janousek J, Strmen E, Gervais F. Purification of murine Kupffer cells by centrifugal elutriation. J Immunol Meth 1993; 164: 109–117
   Google Scholar
• Sipe J D, Gonnerman W A, Loose L D, Knapschaefer G, Xie W J, Franzblau C. Direct binding enzyme-linked immunosorbent assay (ELIS A) for serum amyloid A (SAA). J Immunol Meth 1989; 125: 125–135
   PubMed Web of Science ®Google Scholar
• Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680–685
   PubMed Web of Science ®Google Scholar
• Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci, USA 1979; 76: 4350–4354
   PubMed Web of Science ®Google Scholar
• Meek R L, Benditt E P. Amyloid A gene family expression in different mouse tissues. J Exp Med 1986; 164: 2006–2017
   PubMed Web of Science ®Google Scholar
• Radzioch D, Clayton M, Varesio L. Interferon-α, -ß and -γ augment the levels of rRNA precursors in peritoneal macrophages but not in macrophage cell lines and fibroblasts. J Immunol 1987; 139: 805–812
   PubMedGoogle Scholar
• Barrera L F, Kramnik I, Skamene E, Radzioch D. Nitrite production by macrophages derived from BCG-resistant and -susceptible congenic mouse strains in response to IFN-γ and infection with BCG. Immunology 1994; 82: 457–464
   Google Scholar
• Turnell W G, Sarra R, Baum J O, Pepys M D. Modelling apo-SAA/phospholipid interactions. Protides of the Biological Fluids, H Peeters. Pergamon Press. 1986; 34: 363–366
   Google Scholar
• Kisilevsky R, Subrahmanyan L. Serum amyloid A changes high density lipoprotein's cellular affinity. A clue to serum amyloid A's principal function. Lab Invest 1992; 66: 778–785
   PubMed Web of Science ®Google Scholar
• Siripont J, Tebo J M, Mortensen R F. Receptor-mediated binding of the acute-phase reactant mouse serum amyloid P-component to macrophages. Cell Immunol 1988; 117: 239–252
   Google Scholar
• Loveless R W, Floyd-O'Sullivan G, Raynes J G, Yuen C T, Feizi T. Human serum amyloid P is a multispecific adhesive protein whose ligands include 6-phosphorylated mannose and the 3-sulphated saccharides galactose, N-acetylgalactosamine and glucuronic acid. EMBO J 1992; 33: 813–819
   Google Scholar